InvestorsHub Logo
Followers 8
Posts 628
Boards Moderated 0
Alias Born 05/26/2021

Re: MountainInvestorTN post# 13627

Wednesday, 02/15/2023 12:28:54 PM

Wednesday, February 15, 2023 12:28:54 PM

Post# of 13742
Note From MedolifeRx immunapen team below, midway through my post
… on a side note I myself found The Dec PR to be very candid and informative. Also noteworthy I recently received my back ordered immunipens that are now the reformulated version - new formula that is just as qnta (MedolifeRx Dr Mikaelian) had explained in their last PR. I can 100% attest the formula is different as I used daily for about a years worth of time before the pause in shipping - the viscosity had gone through a couple iterations and truly The new formula they talk about in the Dec 2022 PR indeed has a great velocity and taste as well. ** As stated in their Dec 2022 PR they hoped to get immunapens shipping Q1 of 2023 ** and great news for me as a customer AND as an investor That is exactly what they did - got the newly reformulated shipped!! Which means they ARE getting things done as they outlined in their PR.

Here’s a quoted reply from my letter to MedolifeRx stating I was happy with the new formula and was glad to receive my shipment!
I received a reply just this week (note I order the simple escozine imunapen in the green tube - which as I stated has already resumed shipping as I received my back ordered immunipens a few days ago)

From Medolife; [{ “Our team is delighted to hear you are enjoying the new versions of the Immunapens and I am confident that we should see a steady supply of them available. We're finishing up the red Energy & Focus ones today. I believe this week we'll send out some newsletters and post on our social media regarding a promotion on the Immunapens, so we're expecting to really hit it off this month with those sales.”}]
https://medoliferx.com/

Direct quote from the PR I referred to above [{“Medolife Rx has purchased ingredients from new vendors and is in the process of reformulating the pens at this time with the goal of increasing the potency of the product line. Medolife Rx expects to begin producing and selling new batches of the Immunapen product line starting in Q1 2023”}]
Pr link ;

https://www.globenewswire.com/en/news-release/2022/12/05/2567700/0/en/Quanta-and-Medolife-Rx-Provide-Updates-on-Activities-and-Plans.html

GLTA

This stock has definitely created a level of patience and perseverance I’m not sure any one was predicting would be needed .. HOWEVER in spite of all the challenges Thankfully they haven’t given up … the arrival of the immunipen shipment is a testament they are working towards the goals set forth in the Dec 2022 PR

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.